Lilly opens its checkbook again, and an insider buy at Broadcom captures our attention

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Stocks were mixed on Tuesday as the S & P 500 dipped following a strong rally on Monday, fueled by optimism on a U.S.-Iran agreement. Technology was a notable laggard in Tuesday's session, pulling back after a 3% Nasdaq rally on Monday. The weakness in tech came as SpaceX continued its post-IPO gains, passing Amazon and, briefly, Microsoft , in total market capitalization. Perhaps the softness in tech is a sign that there is only so much capital to go around, with investors selling some of their other tech holdings and reallocating money into SpaceX. Beyond tech, there was a nice broad rally happening as oil and interest rates retreated. U.S. oil benchmark WTI crude has fallen below $76 per barrel , trading at its lowest level since the early days of the Middle East conflict. The financials sector was at the top of the market, followed by industrials and utilities. Financials and industrials are both classic economically sensitive areas. Eli Lilly announced another acquisition , buying 4E Therapeutics for an undisclosed amount. Privately held 4E is developing a pipeline of oral medications designed to treat chronic pain. The company's lead compound is the first MNK inhibitor developed to treat pain and advance to human clinical trials (cancer has been another area of focus for MNK inhibitors). …